Clinical trials: Balance Impairment

Parkinson Disease

Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

• Completed
• Age: 50 to 99 years
• Phase 1/2
• Results posted

This arm is a positron emission tomography (PET) biomechanistic GABA-A receptor target engagement study that includes detailed clinical and motor assessments before and after the i.v.

Trial name

NCT03462641

Testing

Flumazenil

Where

United States

Volunteers

36 people

Sponsor

University of Michigan